sever
acut
respiratori
syndromecoronaviru
sarscov
spike
glycoprotein
alon
mediat
membran
fusion
requir
viru
entri
cell
fusion
also
major
immunogen
target
cml
cellular
molecular
life
scienc
entri
inhibitor
recent
rapid
advanc
knowledg
structur
function
protein
lead
develop
number
candid
vaccin
immunogen
sarscov
entri
inhibitor
viral
envelop
glycoprotein
initi
entri
virus
cell
bind
cell
surfac
receptor
follow
conform
chang
lead
membran
fusion
deliveri
genom
cytoplasm
spike
glycoprotein
coronavirus
except
mediat
bind
host
cell
follow
membran
fusion
major
target
neutral
antibodi
form
characterist
corona
larg
distinct
spike
viral
envelop
complex
surfac
project
also
surround
peripheri
sever
acut
respiratori
syndromecoranaviru
sarscov
particl
level
overal
sequenc
similar
predict
amino
acid
sequenc
sarscov
glycoprotein
glycoprotein
coronavirus
low
pairwis
amino
acid
ident
except
conserv
sequenc
subunit
low
level
sequenc
similar
preclud
definit
conclus
function
structur
similar
fulllength
sarscov
glycoprotein
variou
solubl
fragment
recent
clone
express
character
biochem
biophys
glycoprotein
run
kda
correspond
author
sd
gel
suggest
posttransl
modif
predict
previou
comput
analysi
observ
coronavirus
cell
express
fuse
receptorexpress
cell
neutral
ph
suggest
recombin
glycoprotein
function
membran
fusogen
activ
requir
viral
protein
low
ph
requir
trigger
membran
fusion
fusion
observ
low
receptor
concentr
although
low
ph
requir
membran
fusion
entri
pseudovirus
mediat
glycoprotein
cell
may
occur
low
ph
unknown
mechan
howev
recent
studi
base
pseudotyp
murin
leukemia
viru
particl
confirm
result
entri
found
occur
concentr
nh
cl
mm
suffici
inhibit
vsv
g
proteinmedi
entri
much
lower
use
previous
inhibit
pseudotyp
virus
contain
millimolar
rang
studi
need
clarifi
differ
solubl
ectodomain
e
cleav
signific
degre
protein
coronavirus
class
fusion
protein
observ
classifi
sarscov
protein
except
rule
class
fusion
protein
cleav
expos
ntermin
fusogen
sequenc
fusion
peptid
although
cleavag
could
enhanc
fusion
cleav
defin
exact
locat
boundari
difficult
presum
somewher
residu
around
comput
analysi
suggest
exist
two
heptad
repeat
peptid
nand
ctermin
region
np
cp
respect
form
stabl
complex
sixhelix
bundl
structur
indic
class
fusion
protein
structur
import
intermedi
fusion
process
format
structur
could
disrupt
np
cp
inde
sever
recent
studi
demonstr
sarscov
infect
inhibit
cp
although
case
inhibitori
peptid
concentr
micromolar
rang
except
one
isol
appear
inhibit
nanomolar
concentr
contrast
first
viru
entri
inhibitor
approv
fda
clinic
use
inhibit
viru
entri
much
effici
infect
underli
mechan
differ
known
could
relat
differ
pathway
entri
two
virus
endocytosi
sarscov
entri
cytoplasm
membran
hiv
fragment
contain
ntermin
amino
acid
residu
bound
specif
vero
cell
purifi
solubl
receptor
molecul
togeth
data
inhibit
bind
antibodi
develop
peptid
find
suggest
receptorbind
domain
locat
amino
acid
residu
two
group
obtain
similar
result
found
independ
fold
fragment
short
residu
specif
bind
receptor
molecul
current
fragment
character
better
understand
interact
viru
receptor
also
potenti
inhibitor
viru
entri
block
interact
function
receptor
sarscov
angiotensinconvert
enzym
find
confirm
crystal
structur
recent
report
gener
agreement
two
previous
develop
homolog
model
sbind
domain
propos
involv
residu
ridg
surround
enzymat
site
exact
locat
properti
domain
elucid
bind
high
nanomolar
affin
like
induc
conform
chang
requir
membran
fusion
structur
complex
current
elucid
solubl
variou
fusion
construct
fragment
serv
potent
inhibitor
viru
infect
vivo
entri
sarscov
cell
also
inhibit
antibodi
bind
glycoprotein
human
monoclon
antibodi
potent
inhibit
membran
fusion
nanomolar
concentr
recent
identifi
screen
phage
display
librari
antibodi
compet
bind
glycoprotein
suggest
mechan
neutral
involv
inhibit
virusreceptor
interact
sera
convalesc
sar
patient
also
neutral
viru
antibodi
glycoprotein
appear
play
import
role
viru
neutral
vivo
antibodi
elicit
vivo
use
fulllength
glycoprotein
solubl
fragment
includ
whole
ectodomain
fragment
contain
receptorbind
domain
immun
macaqu
mice
elicit
neutral
antibodi
protect
mice
infect
care
examin
candid
vaccin
requir
possibl
enhanc
effect
anim
modeldepend
effect
conclus
glycoprotein
character
entri
mediat
vaccin
immunogen
inhibitor
target
inhibitor
amazingli
short
period
time
futur
studi
elucid
detail
mechan
function
may
help
develop
clinic
use
inhibitor
vaccin
